Cytokine Inhibition in Chronic Fatigue Syndrome Patients

Trial Profile

Cytokine Inhibition in Chronic Fatigue Syndrome Patients

Completed
Phase of Trial: Phase II/III

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs Anakinra (Primary)
  • Indications Fatigue
  • Focus Therapeutic Use
  • Acronyms CiCFS
  • Most Recent Events

    • 07 Mar 2017 Primary endpoint (Fatigue severity-measured by the Checklist Individual Strength subscale (CIS-fatigue) at 4 weeks) has not been met, according to results published in the Annals of Internal Medicine Journal.
    • 07 Mar 2017 Results published in the Annals of Internal Medicine Journal.
    • 03 Jun 2016 Last checked against ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top